✦ LIBER ✦

Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population

✍ Scribed by Yumi Asukai; Amparo Valladares; Carlos Camps; Eifiona Wood; Kaisa Taipale; Jorge Arellano; Alejo Cassinello; José Antonio Sacristán; Tatiana Dilla

Book ID: 115010049
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 781 KB
Volume: 10
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-10-26

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN114 COST-EFFECTIVENESS ANALYSIS OF PE

PCN114 COST-EFFECTIVENESS ANALYSIS OF PEMETREXED/CISPLATIN IN THE FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN ITALY: RESULTS FOR THE ADENOCARCINOMA HISTOLOGY SUB-POPULATION

✍ L Guidi; S Malik; D Valle; Y Asukai; K Taipale 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

PCN6: MODELLING THE COST-EFFECTIVENESS O

PCN6: MODELLING THE COST-EFFECTIVENESS OF DOCETAXEL IN THE SECOND LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER (NSCLC)

✍ P Sharplin; UK Bose; J Holmes 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

PCN120 COST-UTILITY OF DOCETAXEL COMPARE

PCN120 COST-UTILITY OF DOCETAXEL COMPARED WITH BEST SUPPORTIVE CARE AND PEMETREXED IN SECOND LINE TREATMENT OF NON-SMALL CELL LUNG CANCER IN POLAND

✍ J Rutkowski; B Gwiosda; B Lisiecka; M Wladysiuk; J Lis; R Plisko; P Rys 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Effectiveness and safety of pemetrexed-b

Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysis

✍ Wei-Xiang Qi; Li-Na Tang; Ai-Na He; Zan Shen; Yang Yao 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 366 KB

Pemetrexed versus docetaxel in second li

Pemetrexed versus docetaxel in second line non-small-cell lung cancer: Results and subsets analyses of a multi-center, randomized, exploratory trial in Chinese patients

✍ Rui Li; Li Sun; Jiejun Wang; Jianxin Qian; Zhan Wang; Xiaodong Jiao 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A Randomized Phase II Trial of Oral Topo

A Randomized Phase II Trial of Oral Topotecan Versus Docetaxel in the Second-Line Treatment of Non–Small-Cell Lung Cancer

✍ Suzanne Jones; Dana Thompson; John Barton; Jeff Patton; Dianna Shipley; F. Antho 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 124 KB